BRIEF-Accuray announces results from multi-institutional study

* Data from prospective, 21 center study showed 97 percent cancer patients had cancer control 5 years after SBRT; treatment extremely well-tolerated Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.